Boston Scientific Corporation vs UnitedHealth Group Incorporated — Stock Comparison
Q·Score Breakdown
8.7
Very Bullish
Overall
6.3
Neutral
Quality
Health
Growth
Valuation
Sentiment
BSX
Clean balance sheet with low leverage (0.4× debt-to-equity).
UNH
82% of 28 covering analysts have a positive rating.
⚠ limited growth momentum.
Analyst Consensus
BUY
Target $85.19 (+50.8%)
32 analysts
BUY
Target $387.27 (+5.0%)
26 analysts
Fundamentals
BSX
UNH
23.6×
Trailing P/E
27.9×
15.0×
Forward P/E
17.8×
17.3%
Profit Margin
2.7%
68.9%
Gross Margin
18.8%
14.7%
ROE
12.2%
11.6%
Revenue Growth
2.0%
100.0%
Earnings Growth
0.7%
0.78
Beta
0.41
—
Price / Book
—
$84.0B
Market Cap
$334.9B
$56 – $110
52-Week Range
$235 – $410
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →